Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market sale Executive VP, Head of R&D sold 7,158 shares at an average $75.04 ($537,123)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Executive Officer sold 17,275 shares at an average $64.68 ($1,117,266)
  10. 4 Open-market sale President sold 50,000 shares at an average $70.20 ($3,510,020)
  11. 4 Open-market sale Executive VP, Head of R&D sold 6,700 shares at an average $70.13 ($469,884)
  12. 4 Open-market sale President sold 50,000 shares at $65.00 ($3,250,000)
  13. 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $65.25 ($978,683)
  14. 4 Open-market sale CBO & COO sold 25,000 shares at an average $60.40 ($1,509,971)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes Executive VP, Head of R&D gave up 1,563 shares (to pay taxes)

Page 15 of 26 · 502 filings